Jobs / United States / Astrazeneca Pharmaceuticals Lp

Astrazeneca Pharmaceuticals Lp

National Liaison Lead, TSLP Portfolio

US Posted today

Apply on employer site ↗ Tailor my CV first Source: Company careers site

Optional: we can tailor a CV and cover letter for this job from your real experience first (the first one is free).

Skills this job asks for

TranslationLeadershipCompliancePharmacy

Add your CV (free) to see which of these your CV is missing.

Sponsorship verdict

Sponsorship possible

One solid signal, not two. Worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
  • What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles1 certified filing for “Associate Director, Oncology Portfolio Analytics” (Management Analysts) in MD: $157k–$157k, median $157k.
  • Confirmed live todayWhen a source last listed this job as open.
Details and sources
Employer is on a government sponsor record
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
No salary bar for this route
H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles
1 certified filing for “Associate Director, Oncology Portfolio Analytics” (Management Analysts) in MD: $157k–$157k, median $157k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.

About the role

Are you ready to lead a national Field Medical organization translating breakthrough TSLP science into real-world impact for people living with severe respiratory and inflammatory diseases? As National Liaison Lead, you will set direction for our field teams supporting Tezepelumab and the broader TSLP portfolio across severe uncontrolled asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, and anticipated COPD and future indications. You will turn US medical strategy into focused, measurable field execution—elevating insights from the front line and shaping decisions that accelerate evidence generation, education, and appropriate use. This field-based role spans leadership of Regional Liaison Directors and the MSL organization, guiding scientific engagement with health systems, academic centers, and clinical decision makers nationwide. Can you bring clarity and pace to a complex, multi-indication portfolio while upholding scientific credibility and medical independence? Your leadership will build a high-performing culture, ensure launch readiness, and forge the cross-functional partnerships needed to improve patient outcomes at scale. Accountabilities: • National Field Medical Leadership: Provide clear national direction for RLDs and MSLs, establishing priorities, operating rhythms, and measures of success that advance portfolio goals and elevate scientific credibility. • Strategy to Execution: Translate integrated medical, disease-area, asset, and launch priorities into a coherent field strategy with regionally relevant objectives and accountable delivery. • Launch Readiness and Lifecycle: Lead field readiness for new indications and emerging TSLP medicines, including capabilities, scientific training, certification, stakeholder mapping, insight plans, and deployment. • Portfolio Orchestration: Balance in-market priorities with lifecycle management, evidence-generation needs, and future launches; anticipate capacity, capability, and geographic coverage requirements. • Scientific Engagement Excellence: Ensure balanced, accurate, compliant scientific exchange with priority stakeholders; set standards for preparation, engagement quality, and follow-through. • Insight Generation and Elevation: Define priority scientific questions; synthesize, validate, and elevate field insights to inform medical strategy, evidence plans, and educational initiatives. • Evidence Support: Enable appropriate field support for prioritized Medical Affairs and R&D studies, congresses, advisory boards, expert engagement, and medical education in line with governance. • Change Leadership and Talent: Attract, develop, and retain diverse talent; coach leaders; foster an inclusive, accountable culture that supports growth, learning agility, and ownership of outcomes. • Cross-Functional Partnership: Serve as a core member of respiratory medical leadership; partner across Medical, Development, Commercial, Market Access, Regulatory, Legal, Compliance, and Patient Safety while maintaining medical independence. • Governance and Delivery: Ensure adherence to laws, industry codes, and company policies; manage budgets, resources, vendors, milestones, risks, and performance to deliver with quality and speed. • Innovation and Omnichannel: Identify compliant, innovative approaches to engagement, insight generation, and digital/omnichannel execution; test, learn, and scale what works. Essential Skills/Experience: • Degree in medicine, pharmacy, life sciences, or a related discipline; MD, DO, PharmD, or PhD strongly preferred. • Significant pharmaceutical or biotechnology industry experience, with substantial experience in Medical Affairs and/or a related discipline including Field leadership. • Demonstrated people-leadership experien

Apply on employer site ↗